Amgen Inc. and GSK plc are reportedly set to announce their partnership with TrumpRx.gov. This collaboration is set to offer ...

Johnson & Johnson's much-anticipated oral IL-23 inhibitor, icotrokinra, has claimed FDA approval as a first-line treatment ...

President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his ...

Bristol Myers BMY recently secured a meaningful label expansion for Sotyktu, with the FDA approving the drug for adults with ...

Ayurveda is a comprehensive therapy as it aims at reducing inflammation, enhancing digestion, stabilizing the equilibrium ...

OUR resident specialist and NHS GP, Dr Zoe Williams, shares her expert advice. Today, Dr Zoe helps a reader who has recently ...

Johnson & Johnson JNJ rapidly advanced its pipeline in 2025, attaining significant clinical and regulatory milestones that will help drive growth through the back half of the decade. In 2025, it ...

Debates around the boundaries of medicine, law and personal autonomy took centre stage, and after a significant ruling by the ...

We examine Bristol Myers Squibb’s pipeline strategy and therapeutic priorities in 2026, as it faces a major patent cliff in ...

Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE ...

Lovina tackles the dreaded "junk drawers" as she organizes the house in preparation of washing walls. Eichers will be hosting ...

The patient initially came to see Mark Supiano in 2017 because her family was concerned about her short-term memory loss.